Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Developing the structure of Japan's cancer survivorship guidelines using an expert panel and modified Delphi method.
Matsuoka YJ, Okubo R, Shimizu Y, Tsuji K, Narisawa T, Sasaki J, Sasai H, Akashi-Tanaka S, Hamaguchi T, Iwasa T, Iwata S, Kato T, Kurotani K, Maruyama D, Mori A, Ogawa A, Sakurai N, Shimazu T, Shimizu C, Tabuchi T, Takahashi M, Takano T, Tatematsu N, Uchitomi Y, Watanabe C, Fukui T. Matsuoka YJ, et al. Among authors: mori a. J Cancer Surviv. 2020 Jun;14(3):273-283. doi: 10.1007/s11764-019-00840-3. Epub 2019 Dec 6. J Cancer Surviv. 2020. PMID: 31811478
Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up.
Kurosawa S, Yamaguchi T, Mori A, Matsuura T, Mori T, Tanaka M, Kondo T, Umemoto Y, Goto H, Yoshioka S, Machida S, Sato T, Katayama Y, Kato S, Shono K, Mizuno I, Fujiwara SI, Kohno A, Takahashi M, Fukuda T. Kurosawa S, et al. Among authors: mori a, mori t. J Cancer Surviv. 2022 Oct;16(5):1004-1015. doi: 10.1007/s11764-021-01092-w. Epub 2021 Aug 27. J Cancer Surviv. 2022. PMID: 34449050
Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation.
Kurosawa S, Yamaguchi T, Mori A, Matsuura T, Masuko M, Murata M, Tashiro H, Kako S, Satake A, Hagihara M, Ota S, Saito T, Kagawa K, Matsuo Y, Itonaga H, Uoshima N, Yamaguchi H, Naito K, Takahashi M, Fukuda T. Kurosawa S, et al. Among authors: mori a. J Cancer Surviv. 2023 Jun;17(3):781-794. doi: 10.1007/s11764-022-01250-8. Epub 2022 Sep 1. J Cancer Surviv. 2023. PMID: 36048313
Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in Japan.
Kurosawa S, Mori A, Tsukagoshi M, Onishi Y, Ohwada C, Mori T, Goto H, Asano-Mori Y, Nawa Y, Hino M, Fukuchi T, Mori Y, Yamahana R, Inamoto Y, Fukuda T. Kurosawa S, et al. Among authors: mori y, mori a, mori t. Biol Blood Marrow Transplant. 2020 May;26(5):949-955. doi: 10.1016/j.bbmt.2020.01.008. Epub 2020 Jan 18. Biol Blood Marrow Transplant. 2020. PMID: 31962164 Free article.
Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors.
Kurosawa S, Yamaguchi T, Mori A, Tsukagoshi M, Okuda I, Ikeda M, Ueno T, Saito Y, Aihara Y, Matsuba Y, Fuji S, Yamashita T, Ogawa C, Ito A, Tanaka T, Inamoto Y, Kim SW, Fukuda T. Kurosawa S, et al. Among authors: mori a. Support Care Cancer. 2022 Mar;30(3):2767-2776. doi: 10.1007/s00520-021-06698-5. Epub 2021 Nov 27. Support Care Cancer. 2022. PMID: 34837539
A Support System for Adolescent and Young Adult Patients with Cancer at a Comprehensive Cancer Center.
Ishiki H, Hirayama T, Horiguchi S, Iida I, Kurimoto T, Asanabe M, Nakajima M, Sugisawa A, Mori A, Kojima Y, Udagawa R, Tsuchiya H, Oki M, Shimizu M, Yanai Y, Touma S, Nozawa K, Kojima R, Inamura N, Maehara A, Suzuki T, Satomi E; AYA Support Team, NCCH. Ishiki H, et al. Among authors: mori a. JMA J. 2022 Jan 17;5(1):44-54. doi: 10.31662/jmaj.2021-0106. Epub 2021 Dec 15. JMA J. 2022. PMID: 35224259 Free PMC article. Review.
2,573 results